Werktale:
uit Afrikaans in Engels
uit Nederlands in Engels
uit Duits in Engels

Andrew Griffin
www.andrew-griffin.com, standing by!

Verenigde State
Plaaslike tyd: 01:42 PDT (GMT-7)

Moedertaal: Engels 

No client feedback collected


Rekeningsoort Vryskuttervertaler en/of -tolk, Identity Verified Geverifieerde werfgebruiker
Data security Created by Evelio Clavel-Rosales This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliasies This person is not affiliated with any business or Blue Board record at ProZ.com.
Dienste Translation, Training
Kundigheid
Spesialiseer in:
Biologie (tegnies, chemies, mikro)Sertifikate, diplomas, lisensies, CV's
Chemie, chemiese wetenskap/ingenieursweseMeganika / meganiese ingenieurswese
GenetikaMedies: Gesondheidsorg
Menslike hulpbronneSkepe, seil, vloot
Algemeen / gesprekke / groete / brieweRegte: Patente, handelsmerke, kopiereg

Payment methods accepted Send a payment via ProZ*Pay
Portefeulje Voorbeeldvertalings ingedien: 4
Vertalingonderrig Bachelor's degree - University of Southern Maine
Ervaring Jare vertalingervaring: 20. Geregistreer by ProZ.com: Sep 2000.
ProZ.com Certified PRO certificate(s) N/A
Bewyse uit Duits in Engels (American Translators Association)
uit Nederlands in Engels (American Translators Association)
Lidmaatskap N/A
Sagteware N/A
Webwerf http://www.andrew-griffin.com
CV/Resume CV/Resume (DOC)Engels (PDF)
Bio
Legal, Internet, Training manuals, PowerPoint, Trados, Video transcription

Rates negotiable, generally US$ .10 per target word
Sleutelwoorde: clinical trials, pharmaceutical, patents, medical devices, regulatory, medical, ethics committees, batch records, manufacturing, certificates. See more.clinical trials, pharmaceutical, patents, medical devices, regulatory, medical, ethics committees, batch records, manufacturing, certificates, contracts, lease contracts, litigation, legal. See less.


Profiel laaste opgedateer
Nov 27, 2024